DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Dewar R, Chen ST, Yeckes-Rodin H, Miller K, Khosravi-Far R.
Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker.
Cancer Biol Ther 2011;
11: 552-8
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.